The upregulation of ERK/NF-κB signalling enhanced the binding of NF-κB to Inhibitor of growth 2 (ING2) promoter, leading to the activation of ING2, which subsequently increased MMP-13 expression in colon cancer [64]. Here, MMP13 is linked to malignant colon neoplasm.